Product Portfolio

Marketed Therapies

Below is a list of our company's marketed products. This information is intended only for residents of New Zealand.

 

 

AVONEX (INTERFERON BETA-1A) 

Registered in New Zealand January 2002

TECFIDERA (DIMETHYL FUMARATE)

Registered in New Zealand July 2014

TYSABRI (NATALIZUMAB)

Registered in New Zealand September 2007